28.01.2014 Views

Pesticide residues in food — 2007: Toxicological ... - ipcs inchem

Pesticide residues in food — 2007: Toxicological ... - ipcs inchem

Pesticide residues in food — 2007: Toxicological ... - ipcs inchem

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

123<br />

Table A2. Comparison of parameters of reproductive senescence <strong>in</strong> female Sprague-Dawley rats,<br />

female Fischer 344 rats and humans<br />

Parameter Sprague-Dawley rats Fischer 344 rats Humans<br />

Start of senescence (% of<br />

normal lifespan)<br />

30–40% 60–70% 60–70%<br />

Pr<strong>in</strong>ciple cause of<br />

senescence<br />

Hypothalamic failure to<br />

stimulate LH/FSH<br />

Hypothalamic failure to<br />

control prolact<strong>in</strong> surges<br />

Depletion of ovarian follicle<br />

content<br />

LH-surge capability Lost Ma<strong>in</strong>ta<strong>in</strong>ed Ma<strong>in</strong>ta<strong>in</strong>ed<br />

Predom<strong>in</strong>ant cycle pattern Persistent estrus Pseudopregnancy episodes Menopause<br />

Estrogen/progesterone ratio Elevated/prolonged Reduced Reduced<br />

Prolact<strong>in</strong> secretion Persistently elevated Episodically elevated Reduced<br />

Spontaneous <strong>in</strong>cidence of<br />

mammary tumours<br />

(lifetime)<br />

30–40% 2–5% 8–10%<br />

Pr<strong>in</strong>cipal known factors that<br />

<strong>in</strong>crease risk of mammary<br />

tumour s<br />

Prolact<strong>in</strong>, estrogen,<br />

chemical mutagens<br />

Prolact<strong>in</strong>, estrogen,<br />

chemical mutagens<br />

Family history, parity, diet,<br />

and body weight<br />

Prolact<strong>in</strong> dependence High Median None<br />

From Simpk<strong>in</strong>s et al. (2000)<br />

LH, lute<strong>in</strong>iz<strong>in</strong>g hormone; FSH, follicle-stimulat<strong>in</strong>g hormone.<br />

<strong>in</strong>sul<strong>in</strong> resistance and altered metabolism of carbohydrate and lipid. An association between the<br />

occurrence of PCOS and endometrial hyperplasia and/or cancer has been reported and is biologically<br />

plausible on the basis of estrogenic stimulation of the endometrium unopposed by progesterone. Epidemiological<br />

evaluation of the association between the occurrence of PCOS and ovarian and breast<br />

cancer is not compell<strong>in</strong>g (Eldridge & Delzell, 2000a).<br />

In contrast to women with PCOS, female Sprague-Dawley rats treated with atraz<strong>in</strong>e at high<br />

doses display decreased LH, decreased or unaltered concentrations of androgen, weight loss and no<br />

association with endometrial or ovarian cancer. The earlier appearance and/or elevated <strong>in</strong>cidence of<br />

mammary tumours observed <strong>in</strong> female Sprague-Dawley rats is attributed to persistent exposure to<br />

endogenous estrogen and prolact<strong>in</strong> result<strong>in</strong>g from an earlier failure of the neuro-endocr<strong>in</strong>ological<br />

control mechanisms that regulate the estrous cycle <strong>in</strong> this stra<strong>in</strong> of rat.<br />

Hypothalamic amenorrhoea (HA) is characterized by decreased activity <strong>in</strong> the hypothalamic–<br />

pituitary ovarian axis and low-level exposure to endogenous estrogen (Eldridge & Delzell, 2000b).<br />

Amenorrhoea may occur as a result of a diverse number of conditions, <strong>in</strong>clud<strong>in</strong>g stress, anorexia<strong>in</strong>duced<br />

weight loss, exercise-<strong>in</strong>duced weight loss or failure to ga<strong>in</strong> weight, and the occurrence of<br />

lactation, and results <strong>in</strong> failure to have a normal menstrual cycle. Amenorrhoea, from whatever cause,<br />

is generally associated with a decreased risk for develop<strong>in</strong>g endocr<strong>in</strong>e-mediated tumours <strong>in</strong> the<br />

breast, ovary and uterus. Exposure to atraz<strong>in</strong>e would not lead to a state of persistently <strong>in</strong>creased concentrations<br />

of estrogen <strong>in</strong> women and would not cause an <strong>in</strong>creased <strong>in</strong>cidence of estrogen-mediated<br />

tumours <strong>in</strong> women.<br />

In contrast to hypothalamic amenorrhoea <strong>in</strong> women, female Sprague-Dawley rats given atraz<strong>in</strong>e<br />

at high doses experience prolonged periods of high-level stimulation of estrogen-sensitive tissues<br />

by endogenous estrogens (endocr<strong>in</strong>e age<strong>in</strong>g), which leads to the earlier appearance of mammary<br />

tumours.<br />

ATRAZINE 37–138 JMPR <strong>2007</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!